Skip to main content
. 2021 Feb 5;10(1):165–174. doi: 10.1007/s40123-020-00329-8

Table 1.

The developmental history of Alcon’s acrylic lenses [1, 2] (R. Packard, personal communication with GUA, August 2020; W. Graham, personal communication with GUA, August 2020)

Year Development event
1990 First implantations of the MA60AL multipiece Acrysof IOL in Windsor, UK, and New Orleans, LA, USA, on December 14 (surgeons: Packard and Brint, respectively)
1991–1992 MA60AL: European Core Study and parallel FDA clinical study
1994 Multipiece MA60AL model approvals: CE mark (notified body TUV) and FDA pre-market approval
1995

Development of Acrysof single-piece design

Problems with “Acrysert” pack and glistenings lead to product withdrawal in the USA

1997 Single-piece clinical studies start
1999 Single-piece clinical studies completed
2000 Single-piece Acrysof approval and market release
2001 New variations of one-piece for smaller incision injection
2003 “Yellow” Acrysof Natural available. Multifocal Acrysof ReSTOR launched outside the USA. Trials on Acrysof toric and Wavefront IOLs begin
2005 Launch of Acrysof toric and IQ lenses
2007 Acrysof Aspheric ReSTOR+ 3.0 launched in Europe
2010 Acrysof Aspheric ReSTOR Toric launched in Europe
2012 Acrysof Aspheric ReSTOR+ 2.5 launched in Europe
2013 Thomes & Callaghan report on improved manufacturing process—improvements to minimize glistenings
2015 Acrysof PanOptix launched outside the USA
2017 Clareon introduced in Europe